Allscripts-Misys Healthcare (MDRX) Reports In-Line Q4 EPS; Issues FY12 EPS, Revs Outlook
Allscripts-Misys Healthcare (NASDAQ: MDRX) reported Q4 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $388.2 million versus the consensus estimate of $379.03 million.
Allscripts-Misys Healthcare sees FY2012 EPS of $1.06-$1.10, versus the consensus of $1.10. Allscripts-Misys Healthcare sees FY2012 revenue of $1.62-$1.65 million, versus the consensus of $1.62 million.
For earnings history and earnings-related data on Allscripts-Misys Healthcare (MDRX) click here.
Allscripts-Misys Healthcare sees FY2012 EPS of $1.06-$1.10, versus the consensus of $1.10. Allscripts-Misys Healthcare sees FY2012 revenue of $1.62-$1.65 million, versus the consensus of $1.62 million.
For earnings history and earnings-related data on Allscripts-Misys Healthcare (MDRX) click here.